Target intelligence / Profile preview

RNA, 5S ribosomal pseudogene 269 (RNA5SP269)

Target
RNA5SP269
Molecular classification
Other (Pseudogene)
01

Overview

RNA, 5S ribosomal pseudogene 269 is a processed pseudogene derived from the 5S ribosomal RNA gene[2]. Pseudogenes are non-functional genomic sequences that share homology with functional genes but generally lack protein-coding potential due to disabling mutations or lack regulatory elements needed for expression[2]. Processed pseudogenes like RNA5SP269 originate from reverse transcription and integration of RNA transcripts and are typically not transcribed or translated[2]. Although 5S rRNA plays crucial structural and regulatory roles in ribosome assembly and function[1][3][5], the pseudogene (RNA5SP269) does not produce a functional RNA or protein product. While pseudogenes have historically been considered evolutionary "junk" DNA, recent research reveals that some pseudogenes may generate regulatory RNAs—such as antisense transcripts or act as miRNA decoys—that influence gene expression and disease phenotypes[2][4]. Broadly, pseudogene expression profiles can be useful for cancer prognosis and molecular classification, but there is no evidence that RNA5SP269 itself is a therapeutic target, nor are there any known drugs or clinical biomarker applications specific for this pseudogene[4].

Other names
RN5S269RNA, 5S ribosomal 269RNA5SP269
02

Biological functions

Regulatory RNApossible involvement in gene regulation via antisense transcripts, miRNA decoy mechanisms, or as long non-coding RNAs
03

Disease associations

Other (Pseudogenes, including 5S ribosomal pseudogenes, may act as biomarkers in cancer and regulate cancer mechanisms, but are not direct therapeutic targets)
04

Biomarkers

Possible use in cancer subtype classification and prognosis (based on pseudogene expression profiles, not specifically RNA5SP269 but similar classes)

Beyond the preview

Go deeper on RNA, 5S ribosomal pseudogene 269 (RNA5SP269).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 5S ribosomal pseudogene 269 (RNA5SP269).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call